- Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline (Free to read at Pediatric Blood and Cancer) NEW!
- Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy‐induced nausea and vomiting in children with cancer (open access at Pediatric Blood and Cancer)
- Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
- Update (available at Pediatric Blood and Cancer)
- Original Guideline (open access at Pediatric Blood and Cancer)
- Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients
- Focused Update (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Original Guideline (open access at Pediatric Blood and Cancer)
- Quick Summary (PDF)
- Focused Update (open access at Pediatric Blood and Cancer)
- Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline
- Update (open access at Pediatric Blood and Cancer)
- Original Guideline (open access at Pediatic Blood and Cancer)
- Quick Summary (PDF)
- Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review (Pediatric Blood and Cancer – not available as open access)
If you have any questions about any of our processes, please email:
Paula Robinson, MD, MSc
Guideline Methodologist and Program Manager